MEDICA GROUP PLC

Director's Dealing • Dec 2, 2020

National Storage Mechanism | Additional information

RNS Number : 2640H

Medica Group PLC

02 December 2020

Medica Group PLC

Director / PDMR Transaction and Shareholding

Medica Group PLC (LSE: MGP, "Medica" or the "Company"), has received notification from Dr Stephen Davies, Medical Director and Responsible Officer of Medica, that on 30 November 2020 he transferred a total of 521,032 ordinary shares of 0.2p in the Company ("Shares") to his wife, Mary Davies, for nil consideration. In addition, Stephen Davies and his wife have sold a total of 1,079,292 ordinary shares at a price of 120.00p per share.

Following these transactions, Stephen Davies has an interest in  576,634 shares, representing 0.5% of the issued share capital of the Company.

Furthermore, the Company also received a notification from Dr Stuart Quin, Chief Executive Officer of Medica Group PLC, that on 1 December 2020 he transferred a total of 60,000 ordinary shares of 0.2p in the Company ("Shares") to his wife Mallika Quin, for nil consideration. Following this transaction, there has been no change in the number of shares in which Stuart Quin has an interest.

The Notification of Dealing Forms for Dr Stephen Davies and Dr Stuart Quin can be found below.

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dr Stephen Davies

2

Reason for the notification

a)

Position/status

Medical Director and Responsible Officer/PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Medica Group PLC

b)

LEI

213800B8XE5FUSZF5Z16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.2p

GB00BYV24996

b)

Nature of the transaction

Transfer of Ordinary Shares to Mary Davies

c)

Price(s) and volume(s)

Price (s)	Volumes (s)
N/A	521,032

d)

Aggregated information

-     Aggrated volume

-     Price

521,032

N/A

e)

Date of the transaction

30 November 2020

f)

Place of the transaction

Outside a trading venue

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dr Stephen Davies

2

Reason for the notification

a)

Position/status

Medical Director and Responsible Officer/PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Medica Group PLC

b)

LEI

213800B8XE5FUSZF5Z16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.2p

GB00BYV24996

b)

Nature of the transaction

Market sale

c)

Price(s) and volume(s)

Price (s)	Volumes (s)
GBP 120.00	1,031,924

d)

Aggregated information

-     Aggrated volume

-     Price

1,031,924

GBP 120.00

e)

Date of the transaction

30 November 2020

f)

Place of the transaction

XLON

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mary Davies

2

Reason for the notification

a)

Position/status

PCA/ Dr Stephen Davies (Medical Director and Responsible Officer)

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Medica Group PLC

b)

LEI

213800B8XE5FUSZF5Z16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.2p

GB00BYV24996

b)

Nature of the transaction

Market sale

c)

Price(s) and volume(s)

Price (s)	Volumes (s)
GBP 120.00	47,368

d)

Aggregated information

-     Aggrated volume

-     Price

47,368

GBP 120.00

e)

Date of the transaction

30 November 2020

f)

Place of the transaction

XLON

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dr Stuart Quin

2

Reason for the notification

a)

Position/status

Chief Executive Officer/PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Medica Group PLC

b)

LEI

213800B8XE5FUSZF5Z16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.2p

GB00BYV24996

b)

Nature of the transaction

Transfer of Ordinary Shares to Mallika Quin

c)

Price(s) and volume(s)

Price (s)	Volumes (s)
GBP 0	60,000

d)

Aggregated information

-     Aggrated volume

-     Price

60,000

GBP 0

e)

Date of the transaction

1 December 2020

f)

Place of the transaction

Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHKKBBBCBDKKBK